According to filings with the U.S. Securities and Exchange Commission, Crinetics Pharmaceuticals is raising up to $350,000,028.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Marc Wilson played a key role in securing the recent investment.

About Crinetics Pharmaceuticals
This place is about more than a pharmaceutical career. Its about making a real difference in the lives of patients. Thats why were here. Thats why you should maybe think about being here, too. Our mission is to build the leading endocrine company that consistently pioneers new therapeutics to help patients better control their disease and improve their daily lives. Working to accomplish this mission is how we bring our vision to life. For us, that vision is the best possible therapeutics available to all patients with diseases of the endocrine system. We love how that sounds. And we really cant wait to know how it feels.

To learn more about Crinetics Pharmaceuticals, visit http://www.crinetics.com/

Contact:
Marc Wilson, Chief Financial Officer
858-450-6464

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.